FindTrial
Sign In

The predictive value of combination of SLPI and NGAL in AKI after cardiac valve surgery

The predictive value of combination of SLPI and NGAL in AKI after cardiac valve surgery

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000032247
Enrollment
Unknown
Registered
2020-04-24
Start date
2020-04-30
Completion date
Unknown
Last updated
2020-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute kidney injury after cardiac valve surgery

Interventions

Gold Standard:Clinical outcome
Index test:Blood&#32
and&#32
urine&#32
NGAL,&#32
SLPI&#32
concentration

Sponsors

Department of Critical Care Medicine, Sichuan Academy of Medical Sciences and Sichuan Provincial People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Aged >=18 years old; 2. Patients undergoing elective cardiac valve replacement or angioplasty in our hospital; 3. Patients or their guardians sign an informed consent form.

Exclusion criteria

Exclusion criteria: 1. Patients with kidney impairment before surgery; 2. Patients with chronic kidney dysfunction and need to dialysis; 3. Patients who need emergency surgery; 4. Patients with malignant tumor; 5. Patients who disagree to be involved.

Design outcomes

Primary

MeasureTime frame
SLPI;NGAL;SEN, SPE, ACC, AUC of ROC;—

Countries

China

Contacts

Public ContactPan Lingai

Department of Critical Care Medicine, Sichuan Provincial People's Hospital

panlingai2004@163.com+86 17708130236

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026